PrEP4All sues federal government over 2025 HIV prevention research agreement Gay City News 4d Biotech Pharma LGBTQ+ All sources
Gilead Sciences, Inc. (GILD) is attracting investor attention: Here is what you should know Zacks 6d Gilead Sciences Inc GILD Pharma
Earnings to watch: Gilead Sciences (GILD) reports Q1 results tomorrow Barchart 19h Pharma Biotechnology Wall Street All sources
Gilead’s pipeline strategy in 2026: A broadening focus beyond HIV Labiotech 14:07 Mon, 27 Apr Biotech Pharma
Novo Nordisk, Eli Lilly fined by French regulator over obesity drug promotions FiercePharma 9h Novo Nordisk France Eli Lilly
CellCentric pockets $220m for blood cancer programme pharmaphorum 10h Biotech Blood Cancer Biotechnology
